These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 14638540

  • 1. Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions.
    Thukkani AK, McHowat J, Hsu FF, Brennan ML, Hazen SL, Ford DA.
    Circulation; 2003 Dec 23; 108(25):3128-33. PubMed ID: 14638540
    [Abstract] [Full Text] [Related]

  • 2. Myeloperoxidase-derived reactive chlorinating species from human monocytes target plasmalogens in low density lipoprotein.
    Thukkani AK, Albert CJ, Wildsmith KR, Messner MC, Martinson BD, Hsu FF, Ford DA.
    J Biol Chem; 2003 Sep 19; 278(38):36365-72. PubMed ID: 12869568
    [Abstract] [Full Text] [Related]

  • 3. Reactive chlorinating species produced by myeloperoxidase target the vinyl ether bond of plasmalogens: identification of 2-chlorohexadecanal.
    Albert CJ, Crowley JR, Hsu FF, Thukkani AK, Ford DA.
    J Biol Chem; 2001 Jun 29; 276(26):23733-41. PubMed ID: 11301330
    [Abstract] [Full Text] [Related]

  • 4. 2-chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis.
    Marsche G, Heller R, Fauler G, Kovacevic A, Nuszkowski A, Graier W, Sattler W, Malle E.
    Arterioscler Thromb Vasc Biol; 2004 Dec 29; 24(12):2302-6. PubMed ID: 15514213
    [Abstract] [Full Text] [Related]

  • 5. Identification of lysophosphatidylcholine-chlorohydrin in human atherosclerotic lesions.
    Messner MC, Albert CJ, McHowat J, Ford DA.
    Lipids; 2008 Mar 29; 43(3):243-9. PubMed ID: 18256867
    [Abstract] [Full Text] [Related]

  • 6. Reactive chlorinating species produced during neutrophil activation target tissue plasmalogens: production of the chemoattractant, 2-chlorohexadecanal.
    Thukkani AK, Hsu FF, Crowley JR, Wysolmerski RB, Albert CJ, Ford DA.
    J Biol Chem; 2002 Feb 08; 277(6):3842-9. PubMed ID: 11724792
    [Abstract] [Full Text] [Related]

  • 7. The vinyl ether linkages of plasmalogens are favored targets for myeloperoxidase-derived oxidants: a kinetic study.
    Skaff O, Pattison DI, Davies MJ.
    Biochemistry; 2008 Aug 05; 47(31):8237-45. PubMed ID: 18605737
    [Abstract] [Full Text] [Related]

  • 8. Lysophosphatidylcholine enhances cytokine production of endothelial cells via induction of L-type amino acid transporter 1 and cell surface antigen 4F2.
    Takabe W, Kanai Y, Chairoungdua A, Shibata N, Toi S, Kobayashi M, Kodama T, Noguchi N.
    Arterioscler Thromb Vasc Biol; 2004 Sep 05; 24(9):1640-5. PubMed ID: 15178563
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reactive brominating species produced by myeloperoxidase target the vinyl ether bond of plasmalogens: disparate utilization of sodium halides in the production of alpha-halo fatty aldehydes.
    Albert CJ, Crowley JR, Hsu FF, Thukkani AK, Ford DA.
    J Biol Chem; 2002 Feb 15; 277(7):4694-703. PubMed ID: 11836259
    [Abstract] [Full Text] [Related]

  • 12. Hypochlorous acid-mediated generation of glycerophosphocholine from unsaturated plasmalogen glycerophosphocholine lipids.
    Lessig J, Schiller J, Arnhold J, Fuchs B.
    J Lipid Res; 2007 Jun 15; 48(6):1316-24. PubMed ID: 17395985
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques.
    Woods AA, Linton SM, Davies MJ.
    Biochem J; 2003 Mar 01; 370(Pt 2):729-35. PubMed ID: 12456264
    [Abstract] [Full Text] [Related]

  • 16. Mouse brain plasmalogens are targets for hypochlorous acid-mediated modification in vitro and in vivo.
    Ullen A, Fauler G, Köfeler H, Waltl S, Nusshold C, Bernhart E, Reicher H, Leis HJ, Wintersperger A, Malle E, Sattler W.
    Free Radic Biol Med; 2010 Dec 01; 49(11):1655-65. PubMed ID: 20807565
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Covalent adduct formation between the plasmalogen-derived modification product 2-chlorohexadecanal and phloretin.
    Üllen A, Nusshold C, Glasnov T, Saf R, Cantillo D, Eibinger G, Reicher H, Fauler G, Bernhart E, Hallstrom S, Kogelnik N, Zangger K, Oliver Kappe C, Malle E, Sattler W.
    Biochem Pharmacol; 2015 Feb 15; 93(4):470-81. PubMed ID: 25576489
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.